SOURCE: Cytori Therapeutics, Inc.

Cytori Therapeutics, Inc.

August 15, 2011 08:00 ET

CEO Chris Calhoun to Present Corporate Report at Cytori Annual Shareholder Meeting on August 16

SAN DIEGO, CA--(Marketwire - Aug 15, 2011) - Cytori Therapeutics (NASDAQ: CYTX) CEO Chris Calhoun will present a corporate report as part of the Annual Shareholder Meeting on August 16. Cytori will be hosting a webcast of the presentation and meeting on Tuesday, August 16 at 12 PM Eastern Time.

The webcast will be available both live and by replay two hours after the conclusion of the event on the Company's website, under "Webcasts" on the Investor Relations page (http://ir.cytoritx.com).

About Cytori
Cytori is a world leader in providing patients and physicians around the world with medical technologies that harness the potential of adult regenerative cells from adipose tissue. The Celution® System family of medical devices and instruments is being sold into the European and Asian cosmetic and reconstructive surgery markets but is not yet available in the United States. Our StemSource® product line is sold globally for cell banking and research applications. Our PureGraft™ products are available in North America and Europe for fat grafting procedures. www.cytori.com

Contact Information